These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 21975581)

  • 1. An International Survey-based Algorithm for the Pharmacologic Treatment of Chorea in Huntington's Disease.
    Burgunder JM; Guttman M; Perlman S; Goodman N; van Kammen DP; Goodman L
    PLoS Curr; 2011 Aug; 3():RRN1260. PubMed ID: 21975581
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An International Survey-based Algorithm for the Pharmacologic Treatment of Irritability in Huntington's Disease.
    Groves M; van Duijn E; Anderson K; Craufurd D; Edmondson MC; Goodman N; van Kammen DP; Goodman L
    PLoS Curr; 2011 Aug; 3():RRN1259. PubMed ID: 21975525
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An International Survey-based Algorithm for the Pharmacologic Treatment of Obsessive-Compulsive Behaviors in Huntington's Disease.
    Anderson K; Craufurd D; Edmondson MC; Goodman N; Groves M; van Duijn E; van Kammen DP; Goodman L
    PLoS Curr; 2011 Sep; 3():RRN1261. PubMed ID: 21947193
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Management of Huntington's disease: role of tetrabenazine.
    de Tommaso M; Serpino C; Sciruicchio V
    Ther Clin Risk Manag; 2011; 7():123-9. PubMed ID: 21479143
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of chorea associated with Huntington's disease: focus on tetrabenazine.
    Setter SM; Neumiller JJ; Dobbins EK; Wood L; Clark J; DuVall CA; Santiago A
    Consult Pharm; 2009 Jul; 24(7):524-37. PubMed ID: 19689181
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tetrabenazine treatment for Huntington's disease-associated chorea.
    Ondo WG; Tintner R; Thomas M; Jankovic J
    Clin Neuropharmacol; 2002; 25(6):300-2. PubMed ID: 12469001
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The expert consensus guideline series. Optimizing pharmacologic treatment of psychotic disorders. Introduction: methods, commentary, and summary.
    Kane JM; Leucht S; Carpenter D; Docherty JP;
    J Clin Psychiatry; 2003; 64 Suppl 12():5-19. PubMed ID: 14640142
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Current Pharmacological Approaches to Reduce Chorea in Huntington's Disease.
    Coppen EM; Roos RA
    Drugs; 2017 Jan; 77(1):29-46. PubMed ID: 27988871
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tetrabenazine as antichorea therapy in Huntington disease: a randomized controlled trial.
    Huntington Study Group
    Neurology; 2006 Feb; 66(3):366-72. PubMed ID: 16476934
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of tetrabenazine on gait and functional mobility in individuals with Huntington's disease.
    Kegelmeyer DA; Kloos AD; Fritz NE; Fiumedora MM; White SE; Kostyk SK
    J Neurol Sci; 2014 Dec; 347(1-2):219-23. PubMed ID: 25456459
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An experimental model for Huntington's chorea?
    Zeef DH; Jahanshahi A; Vlamings R; Casaca-Carreira J; Santegoeds RG; Janssen ML; Oosterloo M; Temel Y
    Behav Brain Res; 2014 Apr; 262():31-4. PubMed ID: 24412685
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparing Risperidone and Olanzapine to Tetrabenazine for the Management of Chorea in Huntington Disease: An Analysis from the Enroll-HD Database.
    Schultz JL; Kamholz JA; Nopoulos PC; Killoran A
    Mov Disord Clin Pract; 2019 Feb; 6(2):132-138. PubMed ID: 30838312
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tetrabenazine in the treatment of Huntington's disease.
    Paleacu D
    Neuropsychiatr Dis Treat; 2007; 3(5):545-51. PubMed ID: 19381278
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Short-term effects of tetrabenazine on chorea associated with Huntington's disease.
    Kenney C; Hunter C; Davidson A; Jankovic J
    Mov Disord; 2007 Jan; 22(1):10-3. PubMed ID: 17078062
    [TBL] [Abstract][Full Text] [Related]  

  • 15. State-of-the-art pharmacological approaches to reduce chorea in Huntington's disease.
    Gibson JS; Claassen DO
    Expert Opin Pharmacother; 2021 Jun; 22(8):1015-1024. PubMed ID: 33550875
    [No Abstract]   [Full Text] [Related]  

  • 16. Using antipsychotic agents in older patients.
    Alexopoulos GS; Streim J; Carpenter D; Docherty JP;
    J Clin Psychiatry; 2004; 65 Suppl 2():5-99; discussion 100-102; quiz 103-4. PubMed ID: 14994733
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tetrabenazine as anti-chorea therapy in Huntington disease: an open-label continuation study. Huntington Study Group/TETRA-HD Investigators.
    Frank S
    BMC Neurol; 2009 Dec; 9():62. PubMed ID: 20021666
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Survey of the Huntington's Disease Patient and Caregiver Community Reveals Most Impactful Symptoms and Treatment Needs.
    Simpson JA; Lovecky D; Kogan J; Vetter LA; Yohrling GJ
    J Huntingtons Dis; 2016 Dec; 5(4):395-403. PubMed ID: 27983566
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tetrabenazine: Spotlight on Drug Review.
    Kaur N; Kumar P; Jamwal S; Deshmukh R; Gauttam V
    Ann Neurosci; 2016 Sep; 23(3):176-185. PubMed ID: 27721587
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tetrabenazine for the treatment of hyperkinetic movement disorders: a review of the literature.
    Chen JJ; Ondo WG; Dashtipour K; Swope DM
    Clin Ther; 2012 Jul; 34(7):1487-504. PubMed ID: 22749259
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.